RxDoctor Payments Data

Buffy Cook, MD

Family Medicine · Brighton, TNNPI 1063406114

Payments from drug & device makers

$3,655in general payments, 2019–2025

Across 251 payments — averaging $14.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$479
  • AbbVie$459
  • Amgen$367
  • AstraZeneca$168
  • Pfizer$147
  • plus $990 from 17 others

What the payments were for

  • Food & beverage$3,61099%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,655 in reported general payments places this provider in the 75th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$116,171
Medicare patients
263
Services billed
2,417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$73,090
TrulicityDulaglutide52$61,398
MounjaroTirzepatide41$60,348
MyrbetriqMirabegron62$37,122
JardianceEmpagliflozin36$36,056
JanuviaSitagliptin Phosphate31$30,124
EliquisApixaban45$29,914
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$24,186
FarxigaDapagliflozin Propanediol41$23,033
JanumetSitagliptin Phos/Metformin Hcl14$14,618
XareltoRivaroxaban20$14,010
Tresiba Flextouch U-200Insulin Degludec14$9,055
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,761
LinzessLinaclotide12$8,360
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$7,899

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$479$121,74693 claims
Novo NordiskOzempic$1,045$73,09066 claims
Astellas Pharma US IncMyrbetriq$23$37,12262 claims
Boehringer IngelheimJardiance$43$36,05636 claims
GSKTrelegy Ellipta, Anoro Ellipta$115$32,08547 claims
AstraZenecaFarxiga, Breztri Aerosphere$168$31,79455 claims
PfizerEliquis, Paxlovid$147$31,34358 claims
AbbVieLinzess$459$8,36012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Brighton

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →